-
Je něco špatně v tomto záznamu ?
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation
D. Duricova, E. Dvorakova, O. Hradsky, K. Mitrova, M. Durilova, J. Kozeluhova, P. Kohout, K. Zarubova, J. Bronsky, N. Hradska, E. Bronska, M. Adamcova, N. Machkova, V. Hruba, M. Bortlik, M. Lukas, K. Malickova, M. Lukas,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, randomizované kontrolované studie, práce podpořená grantem
PubMed
30239799
DOI
10.1093/ibd/izy294
Knihovny.cz E-zdroje
- MeSH
- adalimumab aplikace a dávkování MeSH
- dítě MeSH
- gastrointestinální látky aplikace a dávkování MeSH
- idiopatické střevní záněty farmakoterapie imunologie MeSH
- infliximab aplikace a dávkování MeSH
- kohortové studie MeSH
- kojenec MeSH
- komplikace těhotenství diagnóza farmakoterapie imunologie MeSH
- lidé MeSH
- matky MeSH
- následné studie MeSH
- předškolní dítě MeSH
- prognóza MeSH
- studie případů a kontrol MeSH
- těhotenství MeSH
- TNF-alfa antagonisté a inhibitory MeSH
- zpožděný efekt prenatální expozice farmakoterapie imunologie MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: Evidence of the impact of in utero exposure to anti-tumor necrosis factor (TNF)-alpha on long-term childhood development is limited. The aim was to assess the impact of in utero exposure to anti-TNF-alpha due to mothers' inflammatory bowel disease (IBD) on long-term postnatal development of exposed children. METHODS: We included consecutive children (≥12 months of age) born to mothers with IBD (2007-2016) treated with anti-TNF-alpha during pregnancy in 3 centers in the Czech Republic. A control group was comprised of unexposed children of non-IBD mothers undergoing mandatory check-ups at general pediatricians' offices. Data on perinatal period, psychomotor development, vaccination, infections, antibiotics, and allergy were collected by treating pediatricians using a predefined questionnaire. RESULTS: Seventy-two exposed and 69 unexposed children were included (median age, 35 and 50 months, respectively). Exposed children had growth and psychomotor development similar to controls. There was no significant difference in infectious complications within the first year of life (23.9% vs 17.4%; P = 0.36) or during the whole follow-up between exposed infants and controls (P = 0.32). Concomitant immunosuppressants during pregnancy and anti-TNF-alpha levels in cord blood were not associated with elevated infection rate within the first year of life (P > 0.05). Over 95% of exposed children had adequate serologic response to vaccination, except for haemophilus and mumps vaccines. Clinically manifested allergy was similar between the groups (P = 0.98). CONCLUSIONS: Anti-TNF-alpha exposure in utero does not seem to have a negative impact on postnatal development of children with regard to infectious complications, allergy, growth, or psychomotor development when compared with unexposed children of non-IBD women.
Department of Internal Medicine Thomayer University Hospital Prague Czech Republic
Department of Internal Medicine University Hospital Plzeň Plzeň Czech Republic
IBD Clinical and Research Center ISCARE IVF a s Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006778
- 003
- CZ-PrNML
- 005
- 20200525142611.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ibd/izy294 $2 doi
- 035 __
- $a (PubMed)30239799
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Duricova, Dana $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic.
- 245 10
- $a Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation / $c D. Duricova, E. Dvorakova, O. Hradsky, K. Mitrova, M. Durilova, J. Kozeluhova, P. Kohout, K. Zarubova, J. Bronsky, N. Hradska, E. Bronska, M. Adamcova, N. Machkova, V. Hruba, M. Bortlik, M. Lukas, K. Malickova, M. Lukas,
- 520 9_
- $a BACKGROUND: Evidence of the impact of in utero exposure to anti-tumor necrosis factor (TNF)-alpha on long-term childhood development is limited. The aim was to assess the impact of in utero exposure to anti-TNF-alpha due to mothers' inflammatory bowel disease (IBD) on long-term postnatal development of exposed children. METHODS: We included consecutive children (≥12 months of age) born to mothers with IBD (2007-2016) treated with anti-TNF-alpha during pregnancy in 3 centers in the Czech Republic. A control group was comprised of unexposed children of non-IBD mothers undergoing mandatory check-ups at general pediatricians' offices. Data on perinatal period, psychomotor development, vaccination, infections, antibiotics, and allergy were collected by treating pediatricians using a predefined questionnaire. RESULTS: Seventy-two exposed and 69 unexposed children were included (median age, 35 and 50 months, respectively). Exposed children had growth and psychomotor development similar to controls. There was no significant difference in infectious complications within the first year of life (23.9% vs 17.4%; P = 0.36) or during the whole follow-up between exposed infants and controls (P = 0.32). Concomitant immunosuppressants during pregnancy and anti-TNF-alpha levels in cord blood were not associated with elevated infection rate within the first year of life (P > 0.05). Over 95% of exposed children had adequate serologic response to vaccination, except for haemophilus and mumps vaccines. Clinically manifested allergy was similar between the groups (P = 0.98). CONCLUSIONS: Anti-TNF-alpha exposure in utero does not seem to have a negative impact on postnatal development of children with regard to infectious complications, allergy, growth, or psychomotor development when compared with unexposed children of non-IBD women.
- 650 _2
- $a adalimumab $x aplikace a dávkování $7 D000068879
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a gastrointestinální látky $x aplikace a dávkování $7 D005765
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a idiopatické střevní záněty $x farmakoterapie $x imunologie $7 D015212
- 650 _2
- $a infliximab $x aplikace a dávkování $7 D000069285
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a matky $7 D009035
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a komplikace těhotenství $x diagnóza $x farmakoterapie $x imunologie $7 D011248
- 650 _2
- $a zpožděný efekt prenatální expozice $x farmakoterapie $x imunologie $7 D011297
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a TNF-alfa $x antagonisté a inhibitory $7 D014409
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dvorakova, Eva $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic.
- 700 1_
- $a Hradsky, Ondrej $u Department of Pediatrics, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Mitrova, Katarina $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic. Department of Pediatrics, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Durilova, Marianna $u Department of Pediatric Surgery, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kozeluhova, Jana $u Department of Internal Medicine, University Hospital Plzeň, Plzeň, Czech Republic.
- 700 1_
- $a Kohout, Pavel $u Department of Internal Medicine, Thomayer University Hospital, Prague, Czech Republic.
- 700 1_
- $a Zarubova, Kristyna $u Department of Pediatrics, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Bronsky, Jiri $u Department of Pediatrics, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Hradska, Nora $u Private practice, Litovel, Czech Republic.
- 700 1_
- $a Bronska, Eva $u Private practice, Prague, Czech Republic.
- 700 1_
- $a Adamcova, Miroslava $u Private practice, Prague, Czech Republic.
- 700 1_
- $a Machkova, Nadezda $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic.
- 700 1_
- $a Hruba, Veronika $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic.
- 700 1_
- $a Bortlik, Martin $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic. Department of Internal Medicine, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic. Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Lukas, Martin $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic.
- 700 1_
- $a Malickova, Karin $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic.
- 700 1_
- $a Lukas, Milan $u IBD Clinical and Research Center, ISCARE IVF, a.s., Prague, Czech Republic.
- 773 0_
- $w MED00002243 $t Inflammatory bowel diseases $x 1536-4844 $g Roč. 25, č. 4 (2019), s. 789-796
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30239799 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200525142610 $b ABA008
- 999 __
- $a ok $b bmc $g 1525636 $s 1096834
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 25 $c 4 $d 789-796 $e 20190314 $i 1536-4844 $m Inflammatory bowel diseases $n Inflamm Bowel Dis $x MED00002243
- LZP __
- $a Pubmed-20200511